- Home
- CSTL vs MSC Comparison
CSTL vs MSC Comparison
Compare CSTL & MSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- MSC
- Stock Information
- Founded
- CSTL 2007
- MSC 2000
- Country
- CSTL United States
- MSC Hong Kong
- Employees
- CSTL N/A
- MSC N/A
- Industry
- CSTL Medical Specialities
- MSC Hotels/Resorts
- Sector
- CSTL Health Care
- MSC Consumer Discretionary
- Exchange
- CSTL Nasdaq
- MSC Nasdaq
- Market Cap
- CSTL 697.9M
- MSC 766.5M
- IPO Year
- CSTL 2019
- MSC 2018
- Fundamental
- Price
- CSTL $22.75
- MSC $3.93
- Analyst Decision
- CSTL Strong Buy
- MSC
- Analyst Count
- CSTL 6
- MSC 0
- Target Price
- CSTL $37.67
- MSC N/A
- AVG Volume (30 Days)
- CSTL 348.6K
- MSC 46.1K
- Earning Date
- CSTL 11-03-2025
- MSC 11-04-2025
- Dividend Yield
- CSTL N/A
- MSC N/A
- EPS Growth
- CSTL N/A
- MSC N/A
- EPS
- CSTL N/A
- MSC N/A
- Revenue
- CSTL $346,269,000.00
- MSC $679,264,000.00
- Revenue This Year
- CSTL N/A
- MSC $8.92
- Revenue Next Year
- CSTL N/A
- MSC N/A
- P/E Ratio
- CSTL N/A
- MSC N/A
- Revenue Growth
- CSTL 20.40
- MSC 15.03
- 52 Week Low
- CSTL $14.59
- MSC $2.30
- 52 Week High
- CSTL $35.84
- MSC $8.00
- Technical
- Relative Strength Index (RSI)
- CSTL 52.78
- MSC 51.79
- Support Level
- CSTL $22.28
- MSC $3.74
- Resistance Level
- CSTL $23.71
- MSC $4.00
- Average True Range (ATR)
- CSTL 1.05
- MSC 0.20
- MACD
- CSTL -0.12
- MSC 0.03
- Stochastic Oscillator
- CSTL 35.90
- MSC 89.02
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.